Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 148 Results

Intervention Indication Therapeutic Area Year Actions
Bintrafusp alfa for advanced, unresectable cervical cancer Bintrafusp alfa (M7824; GSK4045154) Cervical cancer Female Reproductive Cancer 2021 View  |  Download
Bimekizumab for non-radiographic axial spondyloarthritis Bimekizumab (UCB4940) Axial spondyloarthritis Rheumatology 2021 View  |  Download
Bimekizumab for ankylosing spondylitis Bimekizumab (UCB4940) Ankylosing spondylitis Musculoskeletal System 2021 View  |  Download
Bimekizumab for active psoriatic arthritis Bimekizumab (UCB4940) Psoriatic arthritis Dermatology , Rheumatology 2021 View  |  Download
Bimatoprost slow-release for ocular hypertension or open-angle glaucoma Bimatoprost SR Occular Ocular hypertension Ophthalmology 2021 View  |  Download
Betula verrucosa for tree pollen allergy-induced moderate to severe rhinoconjunctivitis Birch allergy vaccine (ALK tree AIT; Betula Verrucosa allergen extract) Tree pollen allergy Immunology 2021 View  |  Download
Beremagene geperpavec for dystrophic epidermolysis bullosa Bercolagene telserpavec (Beremagene geperpavec; KB103) Dystrophic epidermolysis bullosa (DEB) Dermatology 2021 View  |  Download
Bentracimab for reversal of the antiplatelet activity of ticagrelor Bentracimab (PB2452) Bleeding , Uncontrolled bleeding Haematology 2021 View  |  Download
Belzutifan for von Hippel-Lindau disease-associated clear cell renal cell carcinoma – first line Belzutifan (PT2977; MK-6482) Renal cell carcinoma (RCC) Genetic Disorders , Oncology , Renal Cancer 2021 View  |  Download
Belumosudil for graft versus host disease Belumosudil (SLx-2119; KD025; KD-025) Graft versus host disease (GvHD) Immunology 2021 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications